Sedana Medical (SEDANA) Stock Overview
A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
SEDANA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sedana Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 10.60 |
| 52 Week High | SEK 20.30 |
| 52 Week Low | SEK 6.65 |
| Beta | 0.84 |
| 1 Month Change | -14.10% |
| 3 Month Change | -32.14% |
| 1 Year Change | -29.05% |
| 3 Year Change | -44.94% |
| 5 Year Change | -84.47% |
| Change since IPO | 78.15% |
Recent News & Updates
Recent updates
Sedana Medical AB (publ) (STO:SEDANA) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Jul 22
There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 27% Price Jump
Jul 18Analysts Have Made A Financial Statement On Sedana Medical AB (publ)'s (STO:SEDANA) First-Quarter Report
May 09Sedana Medical AB (publ)'s (STO:SEDANA) Shares Climb 35% But Its Business Is Yet to Catch Up
May 04
US Trials And Supplier Acquisition Will Open Global Markets
Successful U.S. trial results and pediatric approvals across multiple countries could significantly boost revenue and market protection, expanding sales demographics.Risks Still Elevated At These Prices As Sedana Medical AB (publ) (STO:SEDANA) Shares Dive 40%
Mar 19Earnings Update: Sedana Medical AB (publ) (STO:SEDANA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Feb 16There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 26% Price Jump
Dec 12kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results
Oct 28Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues
Oct 25After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar
Jun 07Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Apr 28Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
Mar 16Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking
Dec 21We're Hopeful That Sedana Medical (STO:SEDANA) Will Use Its Cash Wisely
Oct 29Sedana Medical (STO:SEDANA) Is In A Good Position To Deliver On Growth Plans
Jul 12Analysts Just Made A Major Revision To Their Sedana Medical AB (publ) (STO:SEDANA) Revenue Forecasts
May 01Shareholder Returns
| SEDANA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -17.2% | 3.7% | 3.9% |
| 1Y | -29.0% | -12.6% | 3.3% |
Return vs Industry: SEDANA underperformed the Swedish Medical Equipment industry which returned -12.6% over the past year.
Return vs Market: SEDANA underperformed the Swedish Market which returned 3.3% over the past year.
Price Volatility
| SEDANA volatility | |
|---|---|
| SEDANA Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.9% |
| 10% least volatile stocks in SE Market | 2.9% |
Stable Share Price: SEDANA's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: SEDANA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 118 | Johannes Doll | www.sedanamedical.com |
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; scavenging tube, a one-piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anaesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anaesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables connection of the exhaust of the ventilator to an active or passive scavenging system.
Sedana Medical AB (publ) Fundamentals Summary
| SEDANA fundamental statistics | |
|---|---|
| Market cap | SEK 1.05b |
| Earnings (TTM) | -SEK 40.65m |
| Revenue (TTM) | SEK 197.61m |
Is SEDANA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEDANA income statement (TTM) | |
|---|---|
| Revenue | SEK 197.61m |
| Cost of Revenue | SEK 58.36m |
| Gross Profit | SEK 139.25m |
| Other Expenses | SEK 179.90m |
| Earnings | -SEK 40.65m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 12, 2026
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 70.47% |
| Net Profit Margin | -20.57% |
| Debt/Equity Ratio | 0% |
How did SEDANA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/26 01:55 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sedana Medical AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Östling | Pareto Securities |
| Filip Wiberg | Pareto Securities |